Company Data
Protagenic Therapeutics Inc
Ticker
PTIX
Current Price
$0.2561 -1.5%
Market Cap
$1.7M
Price Target
Refer to Report
Volume
27.2K
52wk Range
$0.2512 - $1.87
Overview
Protagenic Therapeutics Inc is a biotechnology company focusing on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-base and brain active therapeutics. The company has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.